Extraocular mitochondrial myopathies and their differential diagnoses
Benedikt G H Schoser1, Dieter Pongratz
1Department of Neurology, Friedrich Baur Institute, Ludwig Maximilians University, Munich, Germany. bschoser@med.uni-muenchen.de
Strabismus
|June 9, 2006
Summary
Diagnosing mitochondrial myopathy involves a comprehensive review of clinical, histological, and genetic findings. This approach is crucial for identifying extraocular muscle involvement, particularly progressive external ophthalmoplegia (PEO).
Area of Science:
- Neurology
- Genetics
- Ophthalmology
Background:
- Mitochondrial myopathies are a group of inherited disorders affecting muscle energy production.
- Diagnosis relies on a combination of clinical presentation, family history, and laboratory tests.
- Extraocular muscle involvement is a common manifestation, often presenting as progressive external ophthalmoplegia (PEO).
Purpose of the Study:
- To outline a diagnostic strategy for mitochondrial myopathies presenting with extraocular muscle disease.
- To differentiate PEO from other ocular motility disorders.
- To emphasize the importance of identifying multisystemic involvement in PEO.
Main Methods:
- Clinical evaluation including family history and neurological examination.
- Exclusionary diagnostic tests: electromyography, nerve conduction studies, MRI of orbits.
- Multisystemic feature assessment.
- Diagnostic muscle biopsy: histological and ultrastructural analysis.
- Genetic testing: Southern blotting for common deletions, molecular analysis for specific gene mutations.
Main Results:
- Progressive external ophthalmoplegia (PEO) is the most frequent ocular sign.
- Differential diagnosis of PEO requires excluding conditions like myasthenia gravis and thyroid orbitopathy.
- Muscle biopsy reveals characteristic mitochondrial abnormalities (e.g., ragged-red fibers, cytochrome-C deficiency).
- Genetic analysis identifies specific mitochondrial DNA deletions or nuclear gene mutations.
Conclusions:
- A systematic diagnostic approach is essential for mitochondrial myopathies with ocular manifestations.
- Early identification of PEO necessitates a thorough investigation for systemic mitochondrial disease.
- Histopathological and genetic analyses are critical for confirming the diagnosis and guiding management.
Related Concept Videos
Myasthenia Gravis: Diagnostic Tests
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Disorders of the Skeletal Muscle
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Myasthenia Gravis ll: Pathophysiology
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
Alterations in Muscle Tone lll
Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...
Myasthenia Gravis: Overview and Treatment
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...

